HK39094A - Aqueous steroid formulations for nasal administration - Google Patents

Aqueous steroid formulations for nasal administration Download PDF

Info

Publication number
HK39094A
HK39094A HK39094A HK39094A HK39094A HK 39094 A HK39094 A HK 39094A HK 39094 A HK39094 A HK 39094A HK 39094 A HK39094 A HK 39094A HK 39094 A HK39094 A HK 39094A
Authority
HK
Hong Kong
Prior art keywords
amount
formulation
inflammatory steroid
polysorbate
propylene glycol
Prior art date
Application number
HK39094A
Other languages
German (de)
English (en)
French (fr)
Inventor
Joel Benjamin Eric
Tyabji Anik Shabbir
Tracy Lin Ya-Yin
Original Assignee
Syntex Pharmaceuticals International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Pharmaceuticals International Limited filed Critical Syntex Pharmaceuticals International Limited
Publication of HK39094A publication Critical patent/HK39094A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK39094A 1986-05-22 1994-04-21 Aqueous steroid formulations for nasal administration HK39094A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/866,171 US4782047A (en) 1986-05-22 1986-05-22 Aqueous steroid formulations for nasal administration

Publications (1)

Publication Number Publication Date
HK39094A true HK39094A (en) 1994-04-29

Family

ID=25347059

Family Applications (1)

Application Number Title Priority Date Filing Date
HK39094A HK39094A (en) 1986-05-22 1994-04-21 Aqueous steroid formulations for nasal administration

Country Status (19)

Country Link
US (1) US4782047A (da)
EP (1) EP0246652B1 (da)
JP (1) JP2521291B2 (da)
KR (1) KR950008308B1 (da)
AT (1) ATE65183T1 (da)
AU (1) AU609718B2 (da)
CA (1) CA1288048C (da)
DE (1) DE3771389D1 (da)
DK (1) DK175238B1 (da)
ES (1) ES2031467T3 (da)
FI (1) FI88459C (da)
GR (1) GR3002317T3 (da)
HK (1) HK39094A (da)
IE (1) IE60259B1 (da)
IL (1) IL82615A (da)
IT (1) IT1205667B (da)
NO (1) NO173365C (da)
NZ (1) NZ220394A (da)
ZA (1) ZA873663B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983595A (en) * 1986-05-22 1991-01-08 Syntex (U.S.A.) Inc. Aqueous steroid formulations for nasal administration
JPH0311016A (ja) * 1989-06-09 1991-01-18 Tokyo Tanabe Co Ltd ピリド［１，２―ａ］ピリミジン誘導体の水性製剤
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
US5338732A (en) * 1991-06-18 1994-08-16 Bristol-Myers Squibb Company Megestrol acetate formulation
CA2174324A1 (en) * 1993-10-21 1995-04-27 Katsuya Mukae Pernasal composition and pernasal preparation containing the same
US5762917A (en) * 1994-09-27 1998-06-09 Virotex Corporation Method and composition for cleansing wounds with minimal cytotoxicity for minimal scarring
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
US8466134B1 (en) 1998-06-26 2013-06-18 Athena Neurosciences, Inc. Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
US6241969B1 (en) * 1998-06-26 2001-06-05 Elan Corporation Plc Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
GB9918559D0 (en) * 1999-08-07 1999-10-06 Glaxo Wellcome Kk Novel pharmaceutical formulation
US6610271B2 (en) * 2000-05-10 2003-08-26 University Of Kentucky Research Foundation System and method for intranasal administration of lorazepam
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
EP1315533A4 (en) * 2000-08-15 2007-06-27 Univ Kentucky Res Found PROGRAMMABLE MULTI-DOSE DEVICE FOR INTRANASAL MEDICINE ADMINISTRATION
US20040176359A1 (en) * 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
NZ538405A (en) 2002-08-01 2007-12-21 Aesgen Inc Improved treatment of cancer with glutamine and carbohydrate
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7404489B1 (en) 2003-03-04 2008-07-29 Qol Medical, Llc Cyanocobalamin low viscosity aqueous formulations for intranasal delivery
JP5238779B2 (ja) * 2003-04-25 2013-07-17 ロート製薬株式会社 点鼻剤
JP4632687B2 (ja) * 2003-04-25 2011-02-16 ロート製薬株式会社 点鼻剤
CA2550811C (en) * 2003-12-24 2012-05-01 Jane Hirsh Temperature-stable formulations, and methods of development thereof
GB0400804D0 (en) 2004-01-14 2004-02-18 Innoscience Technology Bv Pharmaceutical compositions
US20060045850A1 (en) * 2004-08-30 2006-03-02 Qpharma, Llc Nasal delivery of cyclodextrin complexes of anti-inflammatory steroids
DK2377557T3 (da) 2004-11-24 2017-02-06 Meda Pharmaceuticals Inc Sammensætninger, der omfatter azelastin, og metoder til brug deraf
JP2009504767A (ja) * 2005-08-17 2009-02-05 フレミング・アンド・カンパニー・ファーマシューティカルズ ビタミンｂ１２鼻用スプレーおよび使用方法
KR100767976B1 (ko) 2006-08-25 2007-10-18 한국유나이티드제약 주식회사 비내 건조증에 효과적인 약제학적 조성물
US20080275030A1 (en) 2007-01-19 2008-11-06 Sveinbjorn Gizurarson Methods and Compositions for the Delivery of a Therapeutic Agent
CN101678112B (zh) 2007-01-19 2016-08-31 哈南亚有限公司 用于递送治疗剂的方法和组合物
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
CA2905587A1 (en) * 2013-03-15 2014-09-18 Medicis Pharmaceutical Corporation Topical compositions of flunisolide and methods of treatment
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
JP6097787B2 (ja) * 2015-06-09 2017-03-15 パル ファーマシューティカル， インコーポレーテッド 鼻内送達用シアノコバラミン低粘度水性製剤
SI3324933T1 (sl) 2015-07-16 2021-04-30 Marinomed Biotech Ag Metoda za izboljšanje topnosti zdravil, ki niso topna v vodi ali ki so nekoliko topna v vodi, v vodi
US11510859B2 (en) 2015-07-16 2022-11-29 Marinomed Biotech Ag Method for improving aqueous solubility of water-insoluble or slightly water-soluble drugs

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2989437A (en) * 1955-06-08 1961-06-20 Upjohn Co Anti-inflammatory and anti-bacterial decongestant nasal spray compositions
MX3864E (es) * 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
US4444762A (en) * 1980-04-04 1984-04-24 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
US4344940A (en) * 1981-11-30 1982-08-17 E. R. Squibb & Sons, Inc. Steroid formulation containing dipotassium EDTA
US4603131A (en) * 1982-04-26 1986-07-29 Bernstein Joel E Method and composition for treating and preventing irritation of the mucous membranes of the nose

Also Published As

Publication number Publication date
FI872231L (fi) 1987-11-23
AU7327387A (en) 1987-11-26
ATE65183T1 (de) 1991-08-15
NZ220394A (en) 1990-04-26
ES2031467T3 (es) 1992-12-16
US4782047A (en) 1988-11-01
JPS62283927A (ja) 1987-12-09
DK258687D0 (da) 1987-05-21
FI872231A0 (fi) 1987-05-21
FI88459B (fi) 1993-02-15
GR3002317T3 (en) 1992-12-30
EP0246652A3 (en) 1988-02-03
DK175238B1 (da) 2004-07-19
DK258687A (da) 1987-11-23
IT1205667B (it) 1989-03-31
IE871335L (en) 1987-11-22
JP2521291B2 (ja) 1996-08-07
NO173365B (no) 1993-08-30
ZA873663B (en) 1988-12-28
FI88459C (fi) 1993-05-25
IE60259B1 (en) 1994-06-29
KR950008308B1 (ko) 1995-07-27
NO872127D0 (no) 1987-05-21
DE3771389D1 (de) 1991-08-22
EP0246652A2 (en) 1987-11-25
EP0246652B1 (en) 1991-07-17
NO872127L (no) 1987-11-23
KR870010862A (ko) 1987-12-18
IT8720621A0 (it) 1987-05-21
AU609718B2 (en) 1991-05-09
IL82615A (en) 1991-11-21
IL82615A0 (en) 1987-11-30
NO173365C (no) 1993-12-08
CA1288048C (en) 1991-08-27

Similar Documents

Publication Publication Date Title
EP0246652B1 (en) Aqueous steroid formulations for nasal administration
US4983595A (en) Aqueous steroid formulations for nasal administration
AU642210B2 (en) Therapeutic use of indole-3-yl-carboxylic acid endo-8- methyl-8-aza-bicyclo(3,2,1)oct-3-yl ester
JP2515788B2 (ja) 目の炎症の治療薬
US6514520B2 (en) Stabilized antihistamine syrup
CA2822683C (en) Bepotastine compositions
US4711906A (en) Liquid diclofenac preparations
IL142494A (en) Storable active substance concentrate with formoterol
EP0973501B1 (en) Aqueous suspension for nasal administration of loteprednol
HU192246B (en) Process for producing of galenic compositions consisting of calcitonin
WO2012127497A1 (en) Stable pharmaceutical compositions of ketorolac or salts thereof
US5538989A (en) Fenbendazole formulations
EP1782816B1 (en) Water-based medicinal composition containing azithromycin and method of preparing the same
JP4393192B2 (ja) リバビリンシロップ処方物
EP4048230B1 (en) Oral gliptin compositions and method for preparation thereof
EP1543826B1 (en) Concentrated aqueous solution of ambroxol
GB2162745A (en) Nasal compositions
EP2289489B1 (en) Compositions comprising cyclohexylamines and aminoadamantanes
EP3189855A1 (en) Oral pharmaceutical solutions containing hydrocortisone sodium phosphate
JPH02503439A (ja) 局所的眼科用途の為のトブラマイシンとステロイドの組合わせ
GB2100599A (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
JPH0354647B2 (da)
EP1121935B1 (en) Pharmaceutical composition containing a small or medium size peptide

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20060521